Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain-Reference-Cited by-同舟云学术

Proclaim™ DRG Neurostimulator System for the management of chronic, intractable pain

Published:2020-07 Issue:4 Volume:10 Page:225-233
ISSN:1758-1869
Container-title:Pain Management
language:en
Short-container-title:Pain Management

Author:

Hagedorn Jonathan M¹^ORCID,Demian Pavli S²,Scarfo Keith-Austin³,Engle Alyson M⁴,Deer Timothy R⁵

Affiliation:

1. Department of Anesthesiology & Perioperative Medicine, Division of Pain Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA

2. The Pain Management Center, 2271 NJ-33 #103, Hamilton Township, NJ 08690, USA

3. Department of Neurosurgery, Warren Alpert Medical School, Brown University, 593 Eddy Street, George 1st Floor, Providence, RI 02903, USA

4. Department of Anesthesiology, University of Pittsburgh School of Medicine, 3471 Fifth Avenue, Suite 402, Pittsburgh, PA 15213, USA

5. The Spine & Nerve Center of The Virginias, 400 Court Street, Suite 100, Charleston, WV 25301, USA

Abstract

Chronic pain is consistently listed as one of the most costly and disabling health problems worldwide. In an effort to treat these suffering individuals, significant amounts of time and energy have been devoted to discover safe and effective pain relieving treatments. Dorsal root ganglion stimulation is the newest treatment modality to be created for chronic intractable pain. In this manuscript, we review the history and development, published research and safety profile of the Proclaim™ DRG Neurostimulator System (Abbott, TX, USA). At last, we offer our outlook on future developments with dorsal root ganglion stimulation.

Publisher

Future Medicine Ltd

Subject

General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pmt-2020-0010

Reference44 articles.

1. US Spending on Personal Health Care and Public Health, 1996-2013

2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study

4. Why Patients Visit Their Doctors: Assessing the Most Prevalent Conditions in a Defined American Population

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining Short- and Long-Term Programming Requirements in Patients Treated With 10-kHz Spinal Cord Stimulation;Neuromodulation: Technology at the Neural Interface;2024-08

2. Dorsal root ganglion stimulator trial;Neuromodulation Techniques for the Spine;2024

3. Dorsal root ganglion stimulation for chemotherapy‐induced peripheral neuropathy;Pain Practice;2023-06

4. The painful shoulder arthroplasty: appropriate work-up and review of interventional pain treatments;JSES Reviews, Reports, and Techniques;2022-08

5. Efecto de las características del paciente en los resultados clínicos más de 12 meses después de la implantación de la estimulación del ganglio de la raíz dorsal: una revisión retrospectiva;NeuroTarget;2022-01-01